Last reviewed · How we verify
NCT06673615
A Cohort Study on Early Stages of Heart Failure
trial in Stages of Heart Failure in 8,000 participants. Currently enrolling.
30 August 2034
Quick facts
| Lead sponsor | Shanghai East Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 8,000 |
| Start date | 15 April 2024 |
| Primary completion | 30 August 2034 |
| Estimated completion | 30 August 2044 |
| Sites | 1 location across China |
Conditions studied
- Stages of Heart Failure — all drugs for Stages of Heart Failure →
Sponsor
Shanghai East Hospital
Who can join
60 and older, any sex, with Stages of Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main goal of this observational study is to learn about the epidemiological characteristics of heart failure among elder population in Beicai community in Shanghai and construct a community-based database and biobank. The main question it aims to answer is: What is the prevalence and prognosis of different stages of heart failure among elder population in community in Shanghai? And what are the influencing factors? What are the best screening strategies and hierarchical management strategies among different stages of heart failure patients in community? Participants are the elderly people aged 60 years or older in Beicai community in China. The follow-up will be programmed every 2 years.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Liao Y, Xu J, Jiao Y, Sun X, et al · · 2026 · PMID 42193373 · DOI 10.3390/biomedicines14051048 -
Implementing community-based heart failure screening in primary care settings: a population-based pilot study in Shanghai, China.
Gong X, Xu J, Wang M, Hu H, et al · · 2025 · PMID 41408608 · DOI 10.1186/s12875-025-03124-1 -
Prevalence of heart failure stages in elderly population: from a community-dwelling elderly people survey.
Huang M, Wang M, Gong X, Guan S, et al · · 2025 · PMID 41254490 · DOI 10.1186/s12877-025-06631-z
Verify or expand the search:
- PubMed search for NCT06673615
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shanghai East Hospital trials
Trials by the same sponsor.
- NCT07519161 — Pharmacological Intervention to Prevent NOAF After TAVR · NA · not yet recruiting
- NCT07516223 — MRI-Assisted Guidance for Non-Essential Tissue Sampling · NA · not yet recruiting
- NCT07279259 — Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management · Phase 2 · recruiting
- NCT07294495 — Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Tr · NA · not yet recruiting
- NCT07290816 — Effect of Non-invasive Neuromodulation on the Quality of Intestinal Cleansing · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06673615 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai East Hospital
- Last refreshed: 5 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06673615.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing